Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector
暂无分享,去创建一个
[1] Lei Zhang,et al. Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome. , 2010, Genome research.
[2] Randall J. Platt,et al. Optical Control of Mammalian Endogenous Transcription and Epigenetic States , 2013, Nature.
[3] Carlos F. Barbas,et al. Regulation of Endogenous Human Gene Expression by Ligand-Inducible TALE Transcription Factors , 2013, ACS synthetic biology.
[4] Christopher M. Vockley,et al. RNA-guided gene activation by CRISPR-Cas9-based transcription factors , 2013, Nature Methods.
[5] P. Mali,et al. Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease. , 2011, Blood.
[6] Wei-Ting Hwang,et al. Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV. , 2014, The New England journal of medicine.
[7] J. Orange,et al. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases , 2008, Nature Biotechnology.
[8] Yunde Zhao,et al. Self-processing of ribozyme-flanked RNAs into guide RNAs in vitro and in vivo for CRISPR-mediated genome editing. , 2014, Journal of integrative plant biology.
[9] G. Church,et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.
[10] Luigi Naldini,et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery , 2007, Nature Biotechnology.
[11] D. Trono,et al. Production and titration of lentiviral vectors. , 2006, Current protocols in neuroscience.
[12] Martin J. Aryee,et al. Dimeric CRISPR RNA-guided FokI nucleases for highly specific genome editing , 2014, Nature Biotechnology.
[13] Morgan L. Maeder,et al. In Situ Genetic Correction of the Sickle Cell Anemia Mutation in Human Induced Pluripotent Stem Cells Using Engineered Zinc Finger Nucleases , 2011, Stem cells.
[14] C. Barbas,et al. Synthetic Zinc Finger Proteins: The Advent of Targeted Gene Regulation and Genome Modification Technologies , 2014, Accounts of chemical research.
[15] C. Gersbach,et al. Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression. , 2014, Methods.
[16] Y. Ohshima,et al. Nucleotide sequences of mouse genomic loci including a gene or pseudogene for U6 (4.8S) nuclear RNA. , 1981, Nucleic acids research.
[17] Albert Jeltsch,et al. Targeted methylation and gene silencing of VEGF-A in human cells by using a designed Dnmt3a-Dnmt3L single-chain fusion protein with increased DNA methylation activity. , 2013, Journal of molecular biology.
[18] D. Persons. Lentiviral vector gene therapy: effective and safe? , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[20] C. Gersbach,et al. Advances in targeted genome editing. , 2012, Current opinion in chemical biology.
[21] R. Maehr,et al. Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells , 2014, Development.
[22] Jeffry D. Sander,et al. CRISPR-Cas systems for editing, regulating and targeting genomes , 2014, Nature Biotechnology.
[23] T. Weng,et al. A novel approach for the construction of multiple shRNA expression vectors , 2007, The journal of gene medicine.
[24] Christof von Kalle,et al. TALEN-based gene correction for epidermolysis bullosa. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] C C Case,et al. Regulation of an Endogenous Locus Using a Panel of Designed Zinc Finger Proteins Targeted to Accessible Chromatin Regions , 2001, The Journal of Biological Chemistry.
[26] J. Keith Joung,et al. Robust, synergistic regulation of human gene expression using TALE activators , 2013, Nature Methods.
[27] Neville E. Sanjana,et al. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.
[28] C C Case,et al. Synthetic Zinc Finger Transcription Factor Action at an Endogenous Chromosomal Site , 2000, The Journal of Biological Chemistry.
[29] E. Lander,et al. Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.
[30] C. Gersbach,et al. Activating human genes with zinc finger proteins, transcription activator-like effectors and CRISPR/Cas9 for gene therapy and regenerative medicine , 2014, Expert opinion on therapeutic targets.
[31] Charles A Gersbach,et al. Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.
[32] Eric P. Bennett,et al. High-efficiency genome editing via 2A-coupled co-expression of fluorescent proteins and zinc finger nucleases or CRISPR/Cas9 nickase pairs , 2014, Nucleic acids research.
[33] Farshid Guilak,et al. Synergistic and tunable human gene activation by combinations of synthetic transcription factors , 2013, Nature Methods.
[34] Jeffrey C. Miller,et al. A rapid and general assay for monitoring endogenous gene modification. , 2010, Methods in molecular biology.
[35] L. Nissim,et al. Multiplexed and programmable regulation of gene networks with an integrated RNA and CRISPR/Cas toolkit in human cells. , 2014, Molecular cell.
[36] Jeffry D Sander,et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins , 2013, Nature Biotechnology.
[37] Luke A. Gilbert,et al. Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression , 2013, Cell.
[38] Seung Woo Cho,et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease , 2013, Nature Biotechnology.
[39] Yilong Li,et al. Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library , 2013, Nature Biotechnology.
[40] Luke A. Gilbert,et al. CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes , 2013, Cell.
[41] Aviv Regev,et al. Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing , 2014, Nature Biotechnology.
[42] Charles A. Gersbach,et al. Light-Inducible Spatiotemporal Control of Gene Activation by Customizable Zinc Finger Transcription Factors , 2012, Journal of the American Chemical Society.
[43] Yarden Katz,et al. Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system , 2013, Cell Research.
[44] Jeffrey C. Miller,et al. Highly efficient endogenous human gene correction using designed zinc-finger nucleases , 2005, Nature.
[45] T. Lu,et al. Tunable and Multifunctional Eukaryotic Transcription Factors Based on CRISPR/Cas , 2013, ACS synthetic biology.
[46] D. Trono,et al. Production and Titration of Lentiviral Vectors , 2006, Current protocols in neuroscience.
[47] R. Jaenisch,et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases , 2009, Nature Biotechnology.
[48] Charles A. Gersbach,et al. Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases , 2011, Nucleic acids research.
[49] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[50] J. Joung,et al. Locus-specific editing of histone modifications at endogenous enhancers using programmable TALE-LSD1 fusions , 2013, Nature Biotechnology.
[51] Feng Zhang,et al. Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA , 2014, Cell.
[52] Prashant Mali,et al. Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing , 2013, Nature Methods.
[53] M. Melli,et al. The in vitro transcription of the 7SK RNA gene by RNA polymerase III is dependent only on the presence of an upstream promoter , 1987, Cell.
[54] Jennifer Doudna,et al. RNA-programmed genome editing in human cells , 2013, eLife.
[55] C. Barbas,et al. ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering. , 2013, Trends in biotechnology.
[56] Morgan L. Maeder,et al. CRISPR RNA-guided activation of endogenous human genes , 2013, Nature Methods.
[57] Hojun Li,et al. In vivo genome editing restores hemostasis in a mouse model of hemophilia , 2011, Nature.
[58] Jeffry D. Sander,et al. Efficient In Vivo Genome Editing Using RNA-Guided Nucleases , 2013, Nature Biotechnology.
[59] Kira S. Makarova,et al. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems , 2013, Nucleic acids research.
[60] U. Schopfer,et al. Chemically Regulated Zinc Finger Transcription Factors* , 2000, The Journal of Biological Chemistry.
[61] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[62] P. Carbon,et al. An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene. , 2001, Nucleic acids research.